Mankyu Park

Director/Board Member at

Coagulant Therapeutics, Inc.

Consumer Services

Finance

Health Technology

Profile

Mankyu is a Principal at DTCP in the Growth Equity team and covers Korea-based investments.
Mankyu came to DTCP from L&S Venture Capital, a leading Korean VC specializing in IT, semiconductors, and display investments.
Prior to that he held positions in the investment banking division of KB Securities and at Partners Group.
Mankyu made investments in IT, AI, Bio/Life science, mobile platforms, and other tech sectors.
Mankyu also led a couple of mid-to-large size deals like Youngin Engineering and Coagulant Therapeutics where top-tier Korean local VCs participated.
Mankyu holds a bachelor’s degree in business administration with concentration on finance from Goizueta Business School, Emory University.

Mankyu Park active positions

Companies	Position	Start
Coagulant Therapeutics, Inc. Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma	Director/Board Member	-

All active positions of Mankyu Park

Former positions of Mankyu Park

Companies	Position	End
DTCP Management GmbH DTCP Management GmbH Investment ManagersFinance Functions as an alternative investment manager	Corporate Officer/Principal	-

See the detail of Mankyu Park's experience

Training of Mankyu Park

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mankyu Park's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Goizueta Business School-Emory Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
DTCP Management GmbH DTCP Management GmbH Investment ManagersFinance Functions as an alternative investment manager	Finance
Coagulant Therapeutics, Inc. Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma	Health Technology